HR 8205 · 119th Congress
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
This bill extends a program designed to speed up the development and approval of treatments for ALS (amyotrophic lateral sclerosis), a serious neurodegenerative disease that affects nerve cells in the brain and spinal cord. The original program was set to expire in 2026, but this bill keeps it running through 2031,…
- Sponsor
- Quigley, Mike (D-Illinois)
- Introduced
- 2026-04-06
- Policy area
- Health
- Latest action
- Became Public Law No: 119-138.
Digging through Congress... 🔍